Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
11 studies found for:    "Keratosis seborrheic"
Show Display Options
Download search resultsDownload the search results for:
"Keratosis seborrheic" (11 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Unknown  Is Cryosurgery or Curettage More Effective at Treating Seborrheic Keratoses?
Condition: Seborrheic Keratosis
Interventions: Procedure: cryosurgery;   Procedure: Curettage
2 Unknown  Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
Condition: Seborrheic Keratosis
Interventions: Drug: A-101 Vehicle;   Drug: A-101 (40) Topical Solution;   Drug: A-101 (32.5) Topical Solution
3 Recruiting A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.
Condition: Seborrheic Keratosis
Interventions: Drug: A-101 Solution;   Other: Vehicle Solution
4 Recruiting A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
Condition: Seborrheic Keratosis
Interventions: Drug: A-101 Solution;   Other: Vehicle Solution
5 Completed Study to Evaluate the Safety and Efficacy of PEP005(Ingenol Mebutate) Gel, 0.05%, in Patients With Seborrhoeic Keratosis
Condition: Seborrheic Keratosis
Intervention: Drug: PEP005 (ingenol mebutate) Gel
6 Completed Study of A-101 for the Treatment of Seborrheic Keratosis
Condition: Seborrheic Keratosis
Intervention: Drug: A-101
7 Completed Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
Condition: Seborrheic Keratosis
Interventions: Drug: A-101 25%;   Drug: A-101 32.5%;   Drug: A-101 40%;   Drug: A-101 Vehicle
8 Recruiting An Open-Label Safety Study of A-101 Solution
Condition: Seborrheic Keratosis
Intervention: Drug: A-101 Solution
9 Completed
Has Results
Dermatosis Papulosa Nigra
Conditions: Facial Dermatoses;   Seborrheic Keratoses
Interventions: Device: Pulsed dye laser;   Procedure: Curettage;   Procedure: Electrodesiccation;   Other: No treatment
10 Completed Optical Biopsy of Human Skin in Conjunction With Laser Treatment
Conditions: Malignant Melanoma,;   Merkel Cell Carcinoma,;   Basal Cell Carcinoma,;   Squamous Cell Carcinoma;   Atypical Nevi,;   Congenital Nevi;   Seborrheic Keratosis,;   Paget's Disease;   Dermatofibroma,;   Kaposi's Sarcoma;   Port Wine Stain;   Hemangioma;   Tattoos;   Scleroderma;   Burns
Intervention: Device: Optical Biopsy imaging
11 Withdrawn Electrocautery vs Q-switch for Seborrheic Keratosis
Condition: Keratosis, Seborrheic
Interventions: Device: Hyfrecator;   Device: 532 nm Q-switched Nd:YAG laser

Indicates status has not been verified in more than two years